305 related articles for article (PubMed ID: 15938631)
21. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
[TBL] [Abstract][Full Text] [Related]
22. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.
Liapis E; McLuckie KI; Lewis PD; Farmer PB; Brown K
Nucleic Acids Res; 2008 Oct; 36(18):5933-45. PubMed ID: 18805907
[TBL] [Abstract][Full Text] [Related]
23. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
[TBL] [Abstract][Full Text] [Related]
24. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
25. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
Watson DE; Cunningham ML; Tindall KR
Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
[TBL] [Abstract][Full Text] [Related]
27. Lack of genotoxicity of tamoxifen in human endometrium.
Carmichael PL; Ugwumadu AH; Neven P; Hewer AJ; Poon GK; Phillips DH
Cancer Res; 1996 Apr; 56(7):1475-9. PubMed ID: 8603387
[TBL] [Abstract][Full Text] [Related]
28. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
29. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
[TBL] [Abstract][Full Text] [Related]
30. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
[TBL] [Abstract][Full Text] [Related]
31. Mutagenesis induced by the nitric oxide donor sodium nitroprusside in mouse cells.
Lee DH; Pfeifer GP
Mutagenesis; 2007 Jan; 22(1):63-7. PubMed ID: 17158787
[TBL] [Abstract][Full Text] [Related]
32. Detection of tamoxifen-DNA adducts on lacI genes using DNA polymerase stop assay.
Cheng RH; Gant TW
Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):189-96. PubMed ID: 10493022
[TBL] [Abstract][Full Text] [Related]
33. Preferential DNA damage in the p53 gene by benzo[a]pyrene metabolites in cytochrome P4501A1-expressing xeroderma pigmentosum group A cells.
Quan T; States JC
Mol Carcinog; 1996 May; 16(1):32-43. PubMed ID: 8634092
[TBL] [Abstract][Full Text] [Related]
34. Relevance of rat liver tumors to human hepatic and endometrial cancer.
Guzelian PS
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-105-S1-21. PubMed ID: 9045309
[TBL] [Abstract][Full Text] [Related]
35. Genotoxicity of malachite green and leucomalachite green in female Big Blue B6C3F1 mice.
Mittelstaedt RA; Mei N; Webb PJ; Shaddock JG; Dobrovolsky VN; McGarrity LJ; Morris SM; Chen T; Beland FA; Greenlees KJ; Heflich RH
Mutat Res; 2004 Jul; 561(1-2):127-38. PubMed ID: 15238237
[TBL] [Abstract][Full Text] [Related]
36. Mutations induced by 1-nitrosopyrene and related compounds during DNA replication in human cells and induction of homologous recombination by these compounds.
Maher VM; Bhattacharyya NP; Mah MC; Boldt J; Yang JL; McCormick JJ
Res Rep Health Eff Inst; 1993 Mar; (55):1-40; discussion 41-51. PubMed ID: 8466678
[TBL] [Abstract][Full Text] [Related]
37. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
You YH; Pfeifer GP
J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
[TBL] [Abstract][Full Text] [Related]
38. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
[TBL] [Abstract][Full Text] [Related]
39. Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells.
Lee JH; Lu HF; Wang DY; Chen DR; Su CC; Chen YS; Yang JH; Chung JG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():217-33. PubMed ID: 17564319
[TBL] [Abstract][Full Text] [Related]
40. Diethylstilbestrol-induced immortalization of human endometrial cells: alterations in p53 and estrogen receptor.
Rinehart CA; Xu LH; Van Le L; Kaufman DG
Mol Carcinog; 1996 Feb; 15(2):115-23. PubMed ID: 8599578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
